Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Teresa L. Parsons"'
Autor:
Ethel D. Weld, Teresa L. Parsons, Ryann Gollings, Marybeth McCauley, Beatriz Grinsztejn, Raphael J. Landovitz, Mark A. Marzinke
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 228:115307
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6f07fea6610cbee83d10509189feadd
https://doi.org/10.1016/j.jpba.2023.115307
https://doi.org/10.1016/j.jpba.2023.115307
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 228:115321
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7799fa7ab36c5d289f4fd72eca572f6
https://doi.org/10.1016/j.jpba.2023.115321
https://doi.org/10.1016/j.jpba.2023.115321
Autor:
Teresa L. Parsons, Omamah Alfarisi, Mark A. Marzinke, Charles Flexner, Gary Maartens, Andrew Owen, Marta Boffito, Maddalena Cerrone, Megan Neary, Anton Pozniak
Publikováno v:
J Antimicrob Chemother
Objectives Tenofovir alafenamide produces lower plasma tenofovir and higher intracellular tenofovir diphosphate (DP) concentrations than tenofovir disoproxil fumarate but it is likely a victim of interactions with rifampicin. We aimed to investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e64a20f44a68f4d924a5a494a36666
https://doi.org/10.1093/jac/dkz068
https://doi.org/10.1093/jac/dkz068
Publikováno v:
Antimicrob Agents Chemother
Tenofovir (TFV) alafenamide fumarate (TAF) is an antiretroviral that has been evaluated in alternative drug delivery systems in several species. The ex vivo stability of TAF was evaluated, and TAF was stable in dog-, sheep-, and macaque-spiked plasma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f11ad46364b9b610b3d4771af4b95b8e
https://pubmed.ncbi.nlm.nih.gov/32540983
https://pubmed.ncbi.nlm.nih.gov/32540983
Publikováno v:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
The novel antiviral prodrug molnupiravir is under evaluation for the treatment of SARS-CoV-2. Molnupiravir is converted to β-D-N4-hydroxycytidine (NHC), which is the primary form found in systemic circulation. β-D-N4-hydroxycytidine-triphosphate (N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f774222de327c46e2fe5966248354006
https://doi.org/10.1016/j.jchromb.2021.122921
https://doi.org/10.1016/j.jchromb.2021.122921
Publikováno v:
The Journal of Applied Laboratory Medicine. 1:400-409
Background A primary modality in the treatment and prevention of malaria is the administration of antimalarial agents. Atovaquone (ATQ) has been used in single-drug and multidrug antimalarial applications; however, studies have demonstrated high inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adad870d34f6845324ed272969eb295b
https://doi.org/10.1373/jalm.2016.021998
https://doi.org/10.1373/jalm.2016.021998
Autor:
Gabor D. Kelen, Jordyn Manucci, Yu Hsiang Hsieh, William Clarke, Thomas C. Quinn, Richard E. Rothman, Oliver Laeyendecker, Eshan U. Patel, Teresa L. Parsons, Mark A. Marzinke
Publikováno v:
AIDS. 30:113-120
OBJECTIVE The Johns Hopkins Hospital Emergency Department has served as a window on the HIV epidemic for 25 years, and as a pioneer in emergency department-based screening/linkage-to-care (LTC) programs. We document changes in the burden of HIV and H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c84a3447a72b3eb842b0a4a01f5e8283
https://doi.org/10.1097/qad.0000000000000896
https://doi.org/10.1097/qad.0000000000000896
Autor:
Michael C. Thigpen, Tebogo M. Segolodi, Clyde E. Hart, Craig W. Hendrix, Alison Swaims-Kohlmeier, Teresa L. Parsons, Carolyn Dawson, Chou Pong Pau, Dawn K. Smith, Richard E. Haaland, Angela Holder, Lynn A. Paxton
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 75:e86-e88
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029a877a98e7858c9bb6c141e0abe968
https://doi.org/10.1097/qai.0000000000001324
https://doi.org/10.1097/qai.0000000000001324
Autor:
Brendan Prideaux, William R. Bishai, Dalin Rifat, Véronique Dartois, Brian Luna, Vincent P. DeMarco, Sanjay K. Jain, Radojka M. Savic, Kelly E. Dooley, Alvaro A. Ordonez, Teresa L. Parsons, Michael E. Urbanowski, Mark A. Marzinke
Publikováno v:
Science translational medicine, vol 10, iss 435
In clinical trials of two rifamycin antibiotics (rifampin and rifapentine) for treating tuberculosis (TB), patients with cavitary lung lesions did not appear to derive benefit from rifapentine. Rifapentine was found not to outperform rifampin, despit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff548a00f4429c399d5616fbc2301c04
https://escholarship.org/uc/item/5nk8g372
https://escholarship.org/uc/item/5nk8g372
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 152
Background The nucleotide reverse transcriptase inhibitor tenofovir (TFV) is widely administered in a disoproxil prodrug form (tenofovir disoproxil fumarate, TDF) for HIV management and prevention. Recently, novel prodrugs tenofovir alafenamide fumar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b23795ace65755b1784a4b4413c3defd
https://pubmed.ncbi.nlm.nih.gov/29433097
https://pubmed.ncbi.nlm.nih.gov/29433097